Literature DB >> 10834980

Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors.

W K Leung1, R S Dassanayake, J Y Yau, L J Jin, W C Yam, L P Samaranayake.   

Abstract

The aim of this study was to investigate oral yeast colonization and oral yeast strain diversity in irradiated (head and neck), dentate, xerostomic individuals. Subjects were recruited from a nasopharyngeal carcinoma clinic and were segregated into group A (age, <60 years [n = 25; average age +/- standard deviation (SD), 48 +/- 6 years; average postirradiation time +/- SD, 5 +/- 5 years]) and group B (age, >/=60 years [n = 8; average age +/- SD, 67 +/- 4 years; average postirradiation time +/- SD, 2 +/- 2 years]) and were compared with age- and sex-matched healthy individuals in group C (age, <60 years [n = 20; average age +/- SD, 44 +/- 12 years] and group D (age, >/=60 years [n = 10; average age, 70 +/- 3 years]). Selective culture of oral rinse samples was carried out to isolate, quantify, and speciate yeast recovery. All test subjects underwent a 3-month comprehensive oral and preventive care regimen plus topical antifungal therapy, if indicated. A total of 12 subjects from group A and 5 subjects from group B were recalled for reassessment of yeast colonization. Sequential (pre- and posttherapy) Candida isolate pairs from patients were phenotypically (all isolate pairs; biotyping and resistotyping profiles) and genotypically (Candida albicans isolate pairs only; electrophoretic karyotyping by pulsed-field gel electrophoresis, restriction fragment length polymorphism [RFLP], and randomly amplified polymorphic DNA [RAPD] assays) evaluated. All isolates were Candida species. Irradiated individuals were found to have a significantly increased yeast carriage compared with the controls. The isolation rate of Candida posttherapy remained unchanged. A total of 9 of the 12 subjects in group A and 3 of the 5 subjects in group B harbored the same C. albicans or Candida tropicalis phenotype at recall. Varying degrees of congruence in the molecular profiles were observed when these sequential isolate pairs of C. albicans were analyzed by RFLP and RAPD assays. Variations in the genotype were complementary to those in the phenotypic characteristics for some isolates. In conclusion, irradiation-induced xerostomia seems to favor intraoral colonization of Candida species, particularly C. albicans, which appeared to undergo temporal modifications in clonal profiles both phenotypically and genotypically following hygienic and preventive oral care which included topical antifungal therapy, if indicated. We postulate that the observed ability of Candida species to undergo genetic and phenotypic adaptation could strategically enhance its survival in the human oral cavity, particularly when salivary defenses are impaired.

Entities:  

Mesh:

Year:  2000        PMID: 10834980      PMCID: PMC86768          DOI: 10.1128/JCM.38.6.2219-2226.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

Review 1.  Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.

Authors:  E Anaissie
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

2.  Biotypes of oral Candida albicans isolates in a Tanzanian child population.

Authors:  M I Matee; L P Samaranayake; F Scheutz; E Simon; E F Lyamuya; J Mwinula
Journal:  APMIS       Date:  1996-09       Impact factor: 3.205

3.  The use of a DNA probe for epidemiological studies of candidiasis in immunocompromised hosts.

Authors:  B C Fox; H L Mobley; J C Wade
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

4.  Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.

Authors:  V Ramirez-Amador; S Silverman; P Mayer; M Tyler; J Quivey
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-08

Review 5.  Oral mycoses in HIV infection.

Authors:  L P Samaranayake
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1992-02

6.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

7.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

8.  Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit.

Authors:  E Bart-Delabesse; H van Deventer; W Goessens; J L Poirot; N Lioret; A van Belkum; F Dromer
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  DNA translocations contribute to chromosome length polymorphisms in Candida albicans.

Authors:  C Thrash-Bingham; J A Gorman
Journal:  Curr Genet       Date:  1992-08       Impact factor: 3.886

10.  Comparison of PCR fingerprinting, by random amplification of polymorphic DNA, with other molecular typing methods for Candida albicans.

Authors:  A Bostock; M N Khattak; R Matthews; J Burnie
Journal:  J Gen Microbiol       Date:  1993-09
View more
  14 in total

Review 1.  A systematic review of oral fungal infections in patients receiving cancer therapy.

Authors:  Rajesh V Lalla; Marie C Latortue; Catherine H Hong; Anura Ariyawardana; Sandra D'Amato-Palumbo; Dena J Fischer; Andrew Martof; Ourania Nicolatou-Galitis; Lauren L Patton; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-05-08       Impact factor: 3.603

2.  Molecular typing of Candida albicans strains isolated from denture wearers by repetitive sequence-based PCR.

Authors:  O Abaci; A Haliki-Uztan; B Ozturk; S Toksavul; M Ulusoy; H Boyacioglu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-29       Impact factor: 3.267

3.  Antifungal efficacy of herbs.

Authors:  Fahad M Samadi; Shaista Suhail; Manjari Sonam; Neeta Sharma; Shruti Singh; Sushil Gupta; Ashwini Dobhal; Harsha Pradhan
Journal:  J Oral Biol Craniofac Res       Date:  2018-06-07

4.  PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions.

Authors:  K L Bartie; D W Williams; M J Wilson; A J Potts; M A Lewis
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  High oral prevalence of Candida krusei in leprosy patients in northern Thailand.

Authors:  P A Reichart; L P Samaranayake; Y H Samaranayake; M Grote; E Pow; B Cheung
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue, malachite green and low-power laser irradiation alone against Candida albicans.

Authors:  Rodrigo C Souza; Juliana Campos Junqueira; Rodnei D Rossoni; Cristiane A Pereira; Egberto Munin; Antonio O C Jorge
Journal:  Lasers Med Sci       Date:  2009-07-05       Impact factor: 3.161

8.  Oral Candidal Carriage in Subjects with Pure Vegetarian and Mixed Dietary Habits.

Authors:  Shankargouda Patil; Roopa S Rao; A Thirumal Raj; D S Sanketh; Sachin Sarode; Gargi Sarode
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 9.  New perspectives on the topical management of recurrent candidiasis.

Authors:  Ana Carolina S Ré; Jayanaraian F Martins; Marcílio Cunha-Filho; Guilherme M Gelfuso; Carolina P Aires; Taís Gratieri
Journal:  Drug Deliv Transl Res       Date:  2021-01-19       Impact factor: 4.617

10.  Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols.

Authors:  Manju Panghal; Vivek Kaushal; Sangeeta Kadayan; Jaya Parkash Yadav
Journal:  BMC Oral Health       Date:  2012-07-20       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.